NANAIMO, British Columbia --(BUSINESS WIRE)--Feb. 25, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced today it will report results for the fourth quarter and full fiscal year ended December
Former Revlon executive, Jon Levin , joins as Chief Operating Officer and former Molson Coors and Pharmaca executive, Michael Kruteck joins as Chief Financial Officer Current Tilray CFO, Mark Castaneda , to stay on in strategic business development role NANAIMO, British Columbia --(BUSINESS
NANAIMO, British Columbia --(BUSINESS WIRE)--Jan. 7, 2020-- Tilray, Inc. , (“ Tilray” or “the Company”) (Nasdaq: TLRY), a global leader in medical cannabis research, cultivation, production and distribution, today announced that Brendan Kennedy , President and Chief Executive Officer, will present
Company signs 2.5 tonne strategic partnership agreement with Canndoc to address growing demand for medical cannabis products in Israeli market Export to Israel originates from Tilray’s Portugal facility; Tilray now exports medical cannabis to 15 countries worldwide NANAIMO, British
